Laboratory study demonstrates trivalent actinide and lanthanide separation, highlighting new ligand potential in nuclear waste management.
This work presents a new type of asymmetric tetradentate N -donor ligand, (4-(6-(1,10-phenanthrolin-2-yl)pyridin-2-yl)-1H-1,2,3-triazol-1-yl)methyl pivalate (PPTMP), designed for the separation of trivalent actinides and lanthanides in nuclear waste management. Solvent extraction studies show that Am(III)/Eu(III) separation is achieved at low nitric acid concentrations, demonstrating the viability of this novel ligand type. The coordination chemistry of the ligand with Ln(III) and An(III) ions was investigated using X-ray diffraction (XRD) as well as nuclear magnetic resonance (NMR) spectroscopy, time-resolved laser fluorescence spectroscopy (TRLFS) and absorption spectroscopy (UV/vis). These methods show the formation of 1:1 and 1:2 complexes in different media, providing insight into the molecular mechanisms of f -element separation and highlighting the need for improved ligand design in nuclear waste management.
No takes yet. Share an insight, caveat, or question.
Greif et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: